- Home
- NBIX vs ENTG Comparison
NBIX vs ENTG Comparison
Compare NBIX & ENTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | ENTG |
|---|---|---|
| Founded | 1992 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.1B |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NBIX | ENTG |
|---|---|---|
| Price | $151.98 | $76.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 8 |
| Target Price | ★ $172.33 | $98.25 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.52% |
| EPS Growth | 12.44 | ★ 26.59 |
| EPS | ★ 4.19 | 1.90 |
| Revenue | $2,682,700,000.00 | ★ $3,222,508,000.00 |
| Revenue This Year | $23.68 | $0.33 |
| Revenue Next Year | $18.02 | $6.33 |
| P/E Ratio | ★ $36.30 | $40.61 |
| Revenue Growth | ★ 19.61 | 0.59 |
| 52 Week Low | $84.23 | $60.75 |
| 52 Week High | $157.67 | $112.36 |
Technical Indicators
Market Signals| Indicator | NBIX | ENTG |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 43.09 |
| Support Level | $139.27 | $72.23 |
| Resistance Level | $144.83 | $75.13 |
| Average True Range (ATR) | 4.59 | 3.56 |
| MACD | 0.49 | -0.13 |
| Stochastic Oscillator | 88.14 | 42.75 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.